Abstract
Lucian Zhao, Raquibul Hannan
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Letter to the editor: Stereotactic ablative radiation therapy for oligoprogressive metastatic RCC: Predictors of prolonged benefit from ongoing systemic therapy. In regard to Zhao et al
2026
Stereotactic ablative radiation therapy for oligoprogressive metastatic RCC: Predictors of prolonged benefit from ongoing systemic therapy
10.1016/j.ijrobp.2026.02.215 · 2026
The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma
10.1007/s12094-022-02793-z · 2022
Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: A multi-institutional study
10.1007/s00066-022-02026-w · 2023
No additional external references are available.